AVXL
$2.40
Anavex Lf SC
($.08)
(3.23%)
AVXL
Earnings Whisper ®
N/A
4th Quarter September 2019
Consensus:  ($0.15)
Revenue:  N/A
Wednesday
Dec 11
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when AVXL reports earnings?
Beat
Meet
Miss

Where is AVXL's stock price going from here?
Up
Flat
Down
Stock chart of AVXL
Analysts
Summary of analysts' recommendations for AVXL
Score
Grade
Pivots
Resistance
$2.60
$2.55
$2.52

$2.46

Support
$2.43
$2.38
$2.34
Tweet
Growth
Description
ANAVEX LIFE SCIENCES CORP. is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of cancer and neurological diseases. The company's proprietary SIGMACEPTOR Discovery Platform involves the rational drug design of compounds that fulfill specific criteria based on unmet market needs and new scientific advances. Selected drug candidates demonstrate high, non-exclusive affinity for sigma receptors, which are involved in the modulation of multiple cellular biochemical signaling pathways.